BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10525938)

  • 1. Clinical application of proliferating cell nuclear antigen, oncoprotein p53 and tumor front grading analysis in patients operated on for laryngeal cancer.
    Morawski K; Gabriel A; Namyslowski G; Ziólkowski A; Pietrawska V; Steplewska K
    Eur Arch Otorhinolaryngol; 1999; 256(8):378-83. PubMed ID: 10525938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of usefulness of PCNA and oncoprotein p53 staining in prediction of the recurrences in subjects operated on for laryngeal carcinoma].
    Morawski K; Namysłowski G; Gabriel A; Pietrawska V; Ziółkowski A; Urbaniec P
    Otolaryngol Pol; 2000; 54(4):393-9. PubMed ID: 11070693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of usefulness of PCNA and protein p53 in subjects with laryngeal cancer with local recurrence].
    Morawski K; Gabriel A; Namysłowski G; Pietrawska V; Ziółkowski A; Urbaniec P
    Otolaryngol Pol; 2000; 54 Suppl 31():174-7. PubMed ID: 10974877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
    Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
    Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.
    Golusinski W; Olofsson J; Szmeja Z; Biczysko W; Krygier-Stojałowska A; Kulczyński B
    Eur Arch Otorhinolaryngol; 1999; 256(6):306-11. PubMed ID: 10456281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of proliferating cell nuclear antigen and bcl-2 expression with tumor front grading and metastasis in laryngeal squamous cell carcinoma.
    Boran C; Yildiz L; Kandemir B; Karagoz F; Baris S; Aydin O
    Neoplasma; 2003; 50(2):139-43. PubMed ID: 12740649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers.
    Welkoborsky HJ; Hinni M; Dienes HP; Mann WJ
    Ann Otol Rhinol Laryngol; 1995 Jul; 104(7):503-10. PubMed ID: 7598360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of proliferating cell nuclear antigen (PCNA) in the advanced cancer of larynx.
    Dobroś W; Ryś J; Niezabitowski A; Olszewski E
    Auris Nasus Larynx; 1998 Sep; 25(3):295-301. PubMed ID: 9799997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F
    Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of PCNA and mutant p53 expression in laryngeal squamous cell carcinoma.
    Buyukbayram H; Cureoglu S; Arslan A; Işikakdogan AR
    Cancer Invest; 2004; 22(2):195-202. PubMed ID: 15199601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx.
    Liu M; Lawson G; Delos M; Jamart J; Chatelain B; Remacle M; Marbaix E
    Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):28-34. PubMed ID: 12520353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
    J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
    Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCNA--a cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions.
    Broich G; Lavezzi AM; Biondo B; Pignataro LD
    In Vivo; 1996; 10(2):175-8. PubMed ID: 8744797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
    Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
    Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of PCNA expression in laryngeal cancer.
    Saraç S; Ayhan A; Hosal AS; Kaya S
    Arch Otolaryngol Head Neck Surg; 1998 Dec; 124(12):1321-4. PubMed ID: 9865753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
    Franchi A; Gallo O; Boddi V; Santucci M
    Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histological clinical features of the primary tumor as prognostic factors in patients with laryngeal carcinoma].
    Starska K; Kulig A; Łukomski M
    Pol Merkur Lekarski; 2003 Jul; 15(85):55-60. PubMed ID: 14593961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.